GGrantIndex
← Search

CLINICAL TRIAL: PHASE II SAFETY AND IMMUNOGENICITY STUDY OF QUADRIVALENT HUMAN P

$22,321M01FY2008RRNIH

Baylor College Of Medicine, Houston TX

Investigators

Linked publications & trials

View original record on NIH RePORTER →